Ranbaxy gets US FDA nod for loratadine tab

By SiliconIndia   |   Wednesday, 20 August 2003, 07:00 Hrs
Printer Print Email Email
NEW DELHI: Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to market a generic version of Schering-Plough Corp's anti-allergy Claritin tablets in the 10mg strength, says FDA site www.fda.gov showed.

Ranbaxy had earlier got a tentative nod for the 10 mg loratadine tablets in December 2001. The drug's patent expired last year and it is being sold in the over-the-counter market in the United States by several generic firms, besides the innovator Schering.

Claritin, once a blockbuster drug in Schering's stable, had US sales of $944 million in the 12 months ended June 2003.


SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..